The Enterprise Value as of November 2024 (TTM) for DiaMedica Therapeutics Inc. (DMAC) is 197.21M

According to DiaMedica Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 197.21M. This represents a change of 64.49% compared to the average of 119.89M of the last 4 quarters.

DiaMedica Therapeutics Inc. (DMAC) Historical Enterprise Value (quarterly & annually)

How has DMAC Enterprise Value performed in the past?

The mean historical Enterprise Value of DiaMedica Therapeutics Inc. over the last ten years is 45.73M. The current 197.21M Enterprise Value has changed 43.02% with respect to the historical average. Over the past ten years (40 quarters), DMAC's Enterprise Value was at its highest in in the September 2024 quarter at 175.36M. The Enterprise Value was at its lowest in in the December 2014 quarter at 2.98M.

DiaMedica Therapeutics Inc. (DMAC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of DiaMedica Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

DiaMedica Therapeutics Inc. (DMAC) Average Enterprise Value

How has DMAC Enterprise Value performed in the past?

The current Enterprise Value of DiaMedica Therapeutics Inc. (DMAC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

DiaMedica Therapeutics Inc. (DMAC) Enterprise Value vs. Peers

How is DMAC’s Enterprise Value compared to its peers?

DiaMedica Therapeutics Inc.’s Enterprise Value is greater than Milestone Pharmaceuticals Inc. (139.34M), greater than Seres Therapeutics, Inc. (158.02M), greater than Inhibikase Therapeutics, Inc. (154.45M), greater than Oncolytics Biotech Inc. (84.27M), greater than scPharmaceuticals Inc. (128.65M), greater than aTyr Pharma, Inc. (138.44M), greater than Lyra Therapeutics, Inc. (23.90M), less than Centessa Pharmaceuticals plc (1.75B), less than Iovance Biotherapeutics, Inc. (2.52B), less than X4 Pharmaceuticals, Inc. (0), greater than Galera Therapeutics, Inc. (38.44M), greater than Terns Pharmaceuticals, Inc. (-7482657.00), less than Day One Biopharmaceuticals, Inc. (222.97M), less than HOOKIPA Pharma Inc. (963.46M), greater than null (-36166707.00),

Build a custom stock screener for DiaMedica Therapeutics Inc. (DMAC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DiaMedica Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

DiaMedica Therapeutics Inc. (DMAC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like DiaMedica Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.